1
Registered trials
1
Recruiting
1
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
G
Urology/Gynaecology (ATC G)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase I (First in Human):
1
Phase I (First in Human)
1 trial-
RecruitingTopadur Pharma Deutschland GmbH Commercial2-[1-(3-{6-[(1E)-(HYDROXYIMINO)METHYL]-5-METHYL-4-OXO-7-PROPYL-3H,4H-PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL}-4-PROPOXYBENZENESULFONYL)PIPERIDIN-4-YL]ETHYL NITRATE; SILDENAFIL CITRATE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Topadur Pharma Deutschland GmbH | Commercial | 1 | Phase I (First in Human) | 1 |
New trials by year
2025
1